BioInvent International (BioInvent)

Oncology Corporate Profile

HQ Location

Ideon Science Park
SE-223 70
Lund, Sweden

Company Description

BioInvent International AB is a research-based pharmaceutical company focused on the discovery and development of innovative antibody-based drugs against cancer. The company has unique expertise in antibody drug development from initial concept to late clinical phase. The screening tool, F.I.R.S.T.TM, and the antibody library, n-CoDeRĀ®, are two patented tools that enable identification of relevant human antibodies and disease targets during the discovery phase. BioInvent has also considerable experience in and a facility for process development and production of antibodies for clinical studies.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BI-505monoclonal antibodyMultiple MyelomaI
BI-1206CDK inhibitorNon-Hodgkin's Lymphoma (NHL)I

View additional information on product candidates here »


Recent News Headlines

There are no news items to display